Refine
Year of publication
- 2016 (154) (remove)
Document Type
- Article (78)
- Conference Proceeding (65)
- Part of a Book (7)
- Book (2)
- Doctoral Thesis (1)
- Report (1)
Language
- English (154) (remove)
Keywords
- Technical Operations Research (2)
- Additive Manufacturing (1)
- Annulus Fibrosus (1)
- Assessment (1)
- Asymptotic efficiency (1)
- Bacillus atrophaeus (1)
- Balance (1)
- Balanced hypergraph (1)
- Building Systems (1)
- Business Simulations (1)
- Cardiac myocytes (1)
- Cardiac tissue (1)
- CellDrum (1)
- Censored data (1)
- Co-managed care (1)
- Collaborative robot (1)
- Computational biomechanics (1)
- Controller Parameter (1)
- DNA biosensor (1)
- Disc Degeneration (1)
Institute
- Fachbereich Medizintechnik und Technomathematik (43)
- IfB - Institut für Bioengineering (29)
- Fachbereich Chemie und Biotechnologie (26)
- Fachbereich Elektrotechnik und Informationstechnik (26)
- Fachbereich Luft- und Raumfahrttechnik (21)
- Fachbereich Bauingenieurwesen (13)
- INB - Institut für Nano- und Biotechnologien (13)
- Fachbereich Maschinenbau und Mechatronik (12)
- MASKOR Institut für Mobile Autonome Systeme und Kognitive Robotik (11)
- Fachbereich Energietechnik (10)
- Institut fuer Angewandte Polymerchemie (5)
- ECSM European Center for Sustainable Mobility (4)
- Fachbereich Wirtschaftswissenschaften (3)
- Nowum-Energy (3)
- Fachbereich Architektur (2)
- Fachbereich Gestaltung (1)
- Solar-Institut Jülich (1)
- ZHQ - Bereich Hochschuldidaktik und Evaluation (1)
Mice that have been genetically humanized for proteins involved in drug metabolism and toxicity and mice engrafted with human hepatocytes are emerging and promising in vivo models for an improved prediction of the pharmacokinetic, drug–drug interaction and safety characteristics of compounds in humans. The specific advantages and disadvantages of these models should be carefully considered when using them for studies in drug discovery and development. Here, an overview on the corresponding genetically humanized and chimeric liver humanized mouse models described to date is provided and illustrated with examples of their utility in drug metabolism and toxicity studies. We compare the strength and weaknesses of the two different approaches, give guidance for the selection of the appropriate model for various applications and discuss future trends and perspectives.